Mattessich Antony C., President & CEO, Director at Ocular Therapeutix, holds 97.90K shares in Ocular Therapeutix (Ticker: OCUL). Most recently, Mattessich Antony C. Bought $40,000 shares of Ocular Therapeutix on Jun 10, 2019 for an estimated value of 112.40K.